Robert Krembil established the Krembil Foundation in 1998. Always generous in his giving, Robert saw the opportunity to evolve his philanthropy in a more focused and structured way. In 2001, Robert partnered with his son to better define the Foundation’s funding priorities. Mark took on the role of President & CEO managing the day-to-day operations and creating a strategic direction for the Foundation. He noticed a gap in funding in the field of brain research and chose to invest in neuroscience.

In his strategic direction, Mark sought to tackle the complex diseases (i.e. dementia) that require significant research to understand their underlying mechanisms. Our current interests have expanded to include research in the areas of neurodegeneration, the immune system and an immunological focus on arthritic diseases. 

The board of directors is composed of the Krembil family. Each director brings with them their own experiences, interests and perspectives that shape the Foundation’s direction and granting strategy. One example of this is the nursing development program that was established in 2004. This collective expertise enables the Foundation to strategically support projects that align with the Foundation’s mission and drive lasting positive change.